NCT03651700View on ClinicalTrials.gov

Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Aphasia
Interventions
DEVICE

Active TMS

Active TMS will be at 90% motor threshold

DEVICE

Sham TMS

Sham TMS will be administered

BEHAVIORAL

CILT

60-90 minutes of CILT will be administered during each treatment session

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

H. Branch Coslett

OTHER

NCT03651700 - Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia | Biotech Hunter | Biotech Hunter